Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

FFI rebalanced

Glad to see that whilst I was enjoying a welcome Thanksgiving break the boys at Fidessa Labs were busy re-calculating the FFI to better reflect dual listed stocks (see The Great Dexia Debate – a resolution). As you can see from the revised data, in first place is the FTSE 100 (FFI 1.55) followed by the respective indices of Amsterdam (FFI 1.45), Paris (FFI 1.34) and then Germany (FFI 1.32). Interestingly, the LSE has now lost around 30% market share to alternative venues if you look at its ten most fragmented stocks. It will be fascinating to see if the new venues are having the same corrosive effect on the FTSE 250 – something we hope to publish in the near future.

As 2008 starts to draw to a close, I am sure that traditional and new venues alike will be thinking about their strategies for 2009. The big guys will be launching their own MTFs – Arca Europe and Baikal – whilst the alternative venues will be looking at how they build on the momentum they have already established. Looks like having an accurate view of fragmentation is going to be an important part of these strategies, and for the firms that use these markets.

Leave a comment

Copyright © 2018 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa group plc.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.